Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

First tranche of Series A raises $5.5mm for Conatus; adds $22mm

Executive Summary

Start-up Conatus Pharmaceuticals (liver treatments) has raised $5.5mm in the first closing of its proposed $27.5mm Series A financing. Aberdare Ventures led the round, which included participation from Advent Venture Partners, Bay City Capital, Hale BioPharma Ventures, and Gilde Healthcare Partners.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies